Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: thanks ignited..

My attempt at removing the "blur" re: PDS (and Alliacense):

PDS was established as a separate corporate entity to collect monies received via patent licensing - owned 50/50 by PTSC and TPL. PDS is simply a conduit for money flow exclusively relating to the MMP.

Likewise, Alliacense was established as a separate corporate entity to pursue infringers for settlements - owned 50/50 by PTSC and TPL. Alliacense is simply the legal "aggressor" for solely the MMP (thus forming a corporate barrier between the MMP and any other assets/patents/operations of PTSC or TPL). Alliacense may engage the services of other legal entities to better pursue its objectives (e.g., T&T for the TX litigation).

Hope this helps.... Corrections welcomed.

SGE

Share
New Message
Please login to post a reply